Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 2 |
2013 | 2 |
2014 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic implications of targeting the PI3Kinase/AKT/mTOR signaling module in melanoma therapy.
Am J Cancer Res. 2012;2(2):178-91. Epub 2012 Feb 15.
Am J Cancer Res. 2012.
PMID: 22485197
Free PMC article.
Histone deacetylase inhibitor sensitizes apoptosis-resistant melanomas to cytotoxic human T lymphocytes through regulation of TRAIL/DR5 pathway.
Jazirehi AR, Kurdistani SK, Economou JS.
Jazirehi AR, et al.
J Immunol. 2014 Apr 15;192(8):3981-9. doi: 10.4049/jimmunol.1302532. Epub 2014 Mar 17.
J Immunol. 2014.
PMID: 24639349
Free PMC article.
Item in Clipboard
Aberrant apoptotic machinery confers melanoma dual resistance to BRAF(V600E) inhibitor and immune effector cells: immunosensitization by a histone deacetylase inhibitor.
Jazirehi AR, Nazarian R, Torres-Collado AX, Economou JS.
Jazirehi AR, et al.
Am J Clin Exp Immunol. 2014 Feb 27;3(1):43-56. eCollection 2014.
Am J Clin Exp Immunol. 2014.
PMID: 24660121
Free PMC article.
Item in Clipboard
Epigenetic regulation of the TRAIL/Apo2L apoptotic pathway by histone deacetylase inhibitors: an attractive approach to bypass melanoma immunotherapy resistance.
Jazirehi AR, Arle D.
Jazirehi AR, et al.
Am J Clin Exp Immunol. 2013 Feb 27;2(1):55-74. Print 2013.
Am J Clin Exp Immunol. 2013.
PMID: 23885325
Free PMC article.
Item in Clipboard
Roles Each of Snail, Yin Yang 1 and RKIP in the Regulation of Tumor Cells Chemo-immuno-resistance to Apoptosis.
Bonavida B, Jazirehi A, Vega MI, Huerta-Yepez S, Baritaki S.
Bonavida B, et al.
For Immunopathol Dis Therap. 2013;4(1):10.1615/ForumImmunDisTher.2013008299. doi: 10.1615/ForumImmunDisTher.2013008299.
For Immunopathol Dis Therap. 2013.
PMID: 24187651
Free PMC article.
Item in Clipboard
Proteasome inhibition blocks NF-κB and ERK1/2 pathways, restores antigen expression, and sensitizes resistant human melanoma to TCR-engineered CTLs.
Jazirehi AR, Economou JS.
Jazirehi AR, et al.
Mol Cancer Ther. 2012 Jun;11(6):1332-41. doi: 10.1158/1535-7163.MCT-11-0814. Epub 2012 Apr 24.
Mol Cancer Ther. 2012.
PMID: 22532603
Free PMC article.
Retracted.
Item in Clipboard
Cite
Cite